Adrien Sportes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adrien Sportes has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Robert Benamouzig
Avicenne Hospital
5 shared publications Florence Mary
Gastroenterology Unit, Bobigny, France
3 shared publicationsCyriaque Bon
2 shared publicationsJean-Marc Sabate
2 shared publications- Michel Bouchoucha
Department of Gastroenterology, Hôpital Avicenne, Bobigny, France
2 shared publications A Zhang
Johns Hopkins University, Evidence-based Practice Center, Johns Hopkins University, Baltimore, MD, USA
1 shared publication
Latest Publications
- 30 March 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 29 (7) , 2217-2224
Efficacy of Endoscopic Treatment of Post-Sleeve Gastrectomy Fistulas According to the Radiological Type
The originality of this retrospective study relies on the evaluation of the effectiveness of the endoscopic internal drainage (EID) according to the type of fistula.
- 30 March 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 29 (7) , 2217-2224
Efficacy of Endoscopic Treatment of Post-Sleeve Gastrectomy Fistulas According to the Radiological Type
The originality of this retrospective study relies on the evaluation of the effectiveness of the endoscopic internal drainage (EID) according to the type of fistula.
- 1 February 2019
- Published by Wiley in United European Gastroenterology Journal
- Vol. 7 (1) , 60-68
Outcomes of endoscopic ultrasound‐guided biliary drainage: A systematic review and meta‐analysis
Background: Success and event rates of endoscopic ultrasound (EUS)‐guided biliary drainage vary with techniques, and results from different studies remain inconsistent.Objective: We conducted a proportion meta‐analysis to evaluate the efficacy and safety of EUS‐guided biliary drainage and compare the outcomes of current procedures.Methods: We searched MEDLINE, Embase, Cochrane and Web of knowledge to identify studies reporting technical success, clinical success and complication rates of EUS‐guided biliary drainage techniques to estimate their clinical and technical efficacy and safety.Results: We identified 17 studies including a total of 686 patients. The overall clinical success and technical success rates were respectively 84% confidence interval (CI) 95% (80–88) and 96% CI 95% (93–98) for hepaticogastrostomy, and respectively 87% CI 95% (82–91) and 95% CI 95 (91–97) for choledochoduodenostomy. Reported adverse event rates were significantly higher (p = 0.01) for hepaticogastrostomy (29% CI 95% (24–34)) compared to choledochoduodenostomy (20% CI 95% (16–25)). Compared with hepaticogastrostomy, the pooled odds ratio for the complication rate of choledochoduodenostomy was 2.01 (1.25; 3.24) (p = 0.0042), suggesting that choledochoduodenostomy might be safer than hepaticogastrostomy.Conclusion: The available literature suggests choledochoduodenostomy may be a safer approach compared to hepaticogastrostomy. Randomized controlled trials with sufficiently large cohorts are needed to compare techniques and confirm these findings.
- 1 February 2019
- Published by Wiley in United European Gastroenterology Journal
- Vol. 7 (1) , 60-68
Outcomes of endoscopic ultrasound‐guided biliary drainage: A systematic review and meta‐analysis
Background: Success and event rates of endoscopic ultrasound (EUS)‐guided biliary drainage vary with techniques, and results from different studies remain inconsistent.Objective: We conducted a proportion meta‐analysis to evaluate the efficacy and safety of EUS‐guided biliary drainage and compare the outcomes of current procedures.Methods: We searched MEDLINE, Embase, Cochrane and Web of knowledge to identify studies reporting technical success, clinical success and complication rates of EUS‐guided biliary drainage techniques to estimate their clinical and technical efficacy and safety.Results: We identified 17 studies including a total of 686 patients. The overall clinical success and technical success rates were respectively 84% confidence interval (CI) 95% (80–88) and 96% CI 95% (93–98) for hepaticogastrostomy, and respectively 87% CI 95% (82–91) and 95% CI 95 (91–97) for choledochoduodenostomy. Reported adverse event rates were significantly higher (p = 0.01) for hepaticogastrostomy (29% CI 95% (24–34)) compared to choledochoduodenostomy (20% CI 95% (16–25)). Compared with hepaticogastrostomy, the pooled odds ratio for the complication rate of choledochoduodenostomy was 2.01 (1.25; 3.24) (p = 0.0042), suggesting that choledochoduodenostomy might be safer than hepaticogastrostomy.Conclusion: The available literature suggests choledochoduodenostomy may be a safer approach compared to hepaticogastrostomy. Randomized controlled trials with sufficiently large cohorts are needed to compare techniques and confirm these findings.
- Open Access
- 21 November 2018
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 06 (12) , E1395-E1397
Endoscopic ultrasound-guided choledochoduodenostomy with a lumen-apposing metal stent through an uncovered metal duodenal stent
Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) in patients with a preexisting duodenal stent is particularly challenging and has a low success rate. Endoscopic ultrasound (EUS)-guided biliary drainage (EUS-BD) has been increasingly used as an alternative to percutaneous transhepatic biliary drainage after failed ERCP. EUS-guided choledochoduodenostomy (EUS-CD) and EUS-guided hepaticogastrostomy (EUS-HGS) have been reported to have similar efficacity. Recently, a novel dedicated fully-covered lumen-apposing metal stent (LAMS) has been developed for EUS-CD (Hot AXIOS; Boston Scientific, Massachusetts, United States). It seems that this new device decreases the morbidity of EUS-CD. We present a case in which EUS-CD with LAMS through an uncovered metal duodenal stent was used successfully.
- 21 November 2018
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 06 (12) , E1395-E1397
Open AccessEndoscopic ultrasound-guided choledochoduodenostomy with a lumen-apposing metal stent through an uncovered metal duodenal stent
Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) in patients with a preexisting duodenal stent is particularly challenging and has a low success rate. Endoscopic ultrasound (EUS)-guided biliary drainage (EUS-BD) has been increasingly used as an alternative to percutaneous transhepatic biliary drainage after failed ERCP. EUS-guided choledochoduodenostomy (EUS-CD) and EUS-guided hepaticogastrostomy (EUS-HGS) have been reported to have similar efficacity. Recently, a novel dedicated fully-covered lumen-apposing metal stent (LAMS) has been developed for EUS-CD (Hot AXIOS; Boston Scientific, Massachusetts, United States). It seems that this new device decreases the morbidity of EUS-CD. We present a case in which EUS-CD with LAMS through an uncovered metal duodenal stent was used successfully.
- 6 March 2018
- Published by Elsevier in Digestive and Liver Disease
- Vol. 50 (12) , 1339-1342
Invitation letter with a standardized form is a reliable tool to exclude increased risk patients from organized fecal immunological testing-based colorectal cancer screening program
- 6 March 2018
- Published by Elsevier in Digestive and Liver Disease
- Vol. 50 (12) , 1339-1342
Invitation letter with a standardized form is a reliable tool to exclude increased risk patients from organized fecal immunological testing-based colorectal cancer screening program
- 7 April 2017
- Published by Lavoisier in Côlon & Rectum
- Vol. 11 (2) , 73-77
Évaluation du risque de cancer colorectal : peut-on s’aider de scores ?
Résumé Un nombre important de cancers colorectaux (CCR) pourraient être évités si les connaissances que nous avons sur les facteurs de risque étaient utilisées pour identifier les patients à haut risque afin de leur proposer des stratégies préventives adaptées. Plusieurs scores estimant le risque d’avoir ou de développer un CCR ont été développés. Les modèles utilisent une sélection a priori d’une à trois variables. Le même lot de paramètres est étudié et inclut l’âge, le sexe, les antécédents familiaux, les antécédents personnels de cancer ou de maladie inflammatoire chronique de l’intestin et une combinaison de facteurs de risque liés au mode de vie. La plupart des modèles évaluaient initialement plus de facteurs que ceux qui étaient ensuite conservés pour réaliser le score. Alors que ces scores ont une capacité réelle à cibler les patients à haut risque, leur utilisation en pratique clinique comme outil de ciblage ou pour la mise en place d’action de prévention reste faible.
- 7 April 2017
- Published by Lavoisier in Côlon & Rectum
- Vol. 11 (2) , 73-77
Évaluation du risque de cancer colorectal : peut-on s’aider de scores ?
Résumé Un nombre important de cancers colorectaux (CCR) pourraient être évités si les connaissances que nous avons sur les facteurs de risque étaient utilisées pour identifier les patients à haut risque afin de leur proposer des stratégies préventives adaptées. Plusieurs scores estimant le risque d’avoir ou de développer un CCR ont été développés. Les modèles utilisent une sélection a priori d’une à trois variables. Le même lot de paramètres est étudié et inclut l’âge, le sexe, les antécédents familiaux, les antécédents personnels de cancer ou de maladie inflammatoire chronique de l’intestin et une combinaison de facteurs de risque liés au mode de vie. La plupart des modèles évaluaient initialement plus de facteurs que ceux qui étaient ensuite conservés pour réaliser le score. Alors que ces scores ont une capacité réelle à cibler les patients à haut risque, leur utilisation en pratique clinique comme outil de ciblage ou pour la mise en place d’action de prévention reste faible.
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S514
Painful Constipation: Abdominal Pain in Patients with Irritable Bowel Syndrome and in Patients with Functional Constipation
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S514
Painful Constipation: Abdominal Pain in Patients with Irritable Bowel Syndrome and in Patients with Functional Constipation
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S691
Influence of the Viscosity of the Bolus on the Qualitative and Quantitative Parameters Measured by High Resolution Esophageal Manometry
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S691
Influence of the Viscosity of the Bolus on the Qualitative and Quantitative Parameters Measured by High Resolution Esophageal Manometry